Experimental colitis in IL‐10‐deficient mice ameliorates in the absence of PTPN22

Experimental colitis in IL‐10‐deficient mice ameliorates in the absence of PTPN22 Interleukin (IL)‐10 plays a key role in controlling intestinal inflammation. IL‐10‐deficient mice and patients with mutations in IL‐10 or its receptor, IL‐10R, show increased susceptibility to inflammatory bowel diseases (IBD). Protein tyrosine phosphatase, non‐receptor type 22 (PTPN22) controls immune cell activation and the equilibrium between regulatory and effector T cells, playing an important role in controlling immune homoeostasis of the gut. Here, we examined the role of PTPN22 in intestinal inflammation of IL‐10‐deficient (IL‐10–/–) mice. We crossed IL‐10–/– mice with PTPN22–/– mice to generate PTPN22–/–IL‐10–/– double knock‐out mice and induced colitis with dextran sodium sulphate (DSS). In line with previous reports, DSS‐induced acute and chronic colitis was exacerbated in IL‐10–/– mice compared to wild‐type (WT) controls. However, PTPN22–/–IL‐10–/– double knock‐out mice developed milder disease compared to IL‐10–/– mice. IL‐17‐promoting innate cytokines and T helper type 17 (Th17) cells were markedly increased in PTPN22–/–IL‐10–/– mice, but did not provide a protctive function. CXCL1/KC was also increased in PTPN22–/–IL‐10–/– mice, but therapeutic injection of CXCL1/KC in IL‐10–/– mice did not ameliorate colitis. These results show that PTPN22 promotes intestinal inflammation in IL‐10‐deficient mice, suggesting that therapeutic targeting of PTPN22 might be beneficial in patients with IBD and mutations in IL‐10 and IL‐10R. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Clinical & Experimental Immunology Wiley

Experimental colitis in IL‐10‐deficient mice ameliorates in the absence of PTPN22

Loading next page...
 
/lp/wiley/experimental-colitis-in-il-10-deficient-mice-ameliorates-in-the-p4bHEUkt2k
Publisher
Wiley
Copyright
© 2019 British Society for Immunology
ISSN
0009-9104
eISSN
1365-2249
D.O.I.
10.1111/cei.13339
Publisher site
See Article on Publisher Site

Abstract

Interleukin (IL)‐10 plays a key role in controlling intestinal inflammation. IL‐10‐deficient mice and patients with mutations in IL‐10 or its receptor, IL‐10R, show increased susceptibility to inflammatory bowel diseases (IBD). Protein tyrosine phosphatase, non‐receptor type 22 (PTPN22) controls immune cell activation and the equilibrium between regulatory and effector T cells, playing an important role in controlling immune homoeostasis of the gut. Here, we examined the role of PTPN22 in intestinal inflammation of IL‐10‐deficient (IL‐10–/–) mice. We crossed IL‐10–/– mice with PTPN22–/– mice to generate PTPN22–/–IL‐10–/– double knock‐out mice and induced colitis with dextran sodium sulphate (DSS). In line with previous reports, DSS‐induced acute and chronic colitis was exacerbated in IL‐10–/– mice compared to wild‐type (WT) controls. However, PTPN22–/–IL‐10–/– double knock‐out mice developed milder disease compared to IL‐10–/– mice. IL‐17‐promoting innate cytokines and T helper type 17 (Th17) cells were markedly increased in PTPN22–/–IL‐10–/– mice, but did not provide a protctive function. CXCL1/KC was also increased in PTPN22–/–IL‐10–/– mice, but therapeutic injection of CXCL1/KC in IL‐10–/– mice did not ameliorate colitis. These results show that PTPN22 promotes intestinal inflammation in IL‐10‐deficient mice, suggesting that therapeutic targeting of PTPN22 might be beneficial in patients with IBD and mutations in IL‐10 and IL‐10R.

Journal

Clinical & Experimental ImmunologyWiley

Published: Sep 1, 2019

Keywords: ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off